References

Acupuncture Allergies Alzheimer's Disease Androgen Anxiety Disorders Asthma Atherosclerosis Attention Deficit Hyperactivity Disorder Bacterial Vaginosis Biofeedback Bipolar Disorder Birth Control Pills Blood Donation and Transfusion Breast Augmentation and Reduction Breast Cancer Breastfeeding Breast Reconstruction Caregiving Cervical Cancer Chiropractic Chlamydia Cholesterol Chronic Fatigue Syndrome Clinical Trials Colon Cancer Contraception Depression Diabetes Dry Eye Syndrome Eating Disorders Endometriosis Epilepsy Estrogen Fibroids Fibromyalgia Fitness Flu/Colds Gastroesophageal Reflux Disease (GERD) Genetic Testing Genital Herpes Glaucoma Gonorrhea Health Insurance Heart Disease Hepatitis High Blood Pressure HIV/AIDS Homeopathy Human Papillomavirus Hypnosis Hysterectomy Incontinence Infertility Irritable Bowel Syndrome Legal Health Tools Liposuction Lung Cancer Lupus Macular Degeneration Medication Safety Menopause Menstrual Disorders Metabolic Syndrome Migraine Multiple Sclerosis Naturopathy Nonsurgical Aesthetic Procedures Nutrition Obesity Ocular Allergies Oral Health Osteoarthritis Osteopathic Medicine Osteoporosis Ovarian Cancer Overactive Bladder Pain Management Pelvic Organ Prolapse Pelvic Pain Peripheral Arterial Disease Polycystic Ovary Syndrome Pregnancy Premenstrual Syndrome Preparing for Surgery Progesterone Rheumatoid Arthritis Schizophrenia Scleroderma Sexual Dysfunction Sinusitis Sjogren's Syndrome Skin Cancer Skin Health Sleep Disorders Smoking Stress Stroke Substance Abuse Tai Chi Teen Health Thyroid Disorders Trichomoniasis Urinary Tract Conditions Urinary Tract Infection Uterine Cancer Varicose Veins Violence Against Women Vulvodynia Weight Management Yeast Infections Yoga

"FDA approves new indication for YAZ to treat emotional and physical symptoms of premenstrual dysphoric disorder." Berlex. October 2006.

"FDA approves contraceptive for continuous use. May 22, 2007." www.fda.gov.

Curtis KM, Chrisman CE, Peterson HB. "Contraception for women in selected circumstances." Obstet Gynecol 2002;99:1100-1112.

"The Emergency Contraception Website." Princeton University Office of Population Research/Association of Reproductive Health Professionals. http://ec.princeton.edu. Last updated August 2005. Date accessed: August 2005.

"Estimates of the Risk of Cardiovascular Death Attributable to Low-Dose Oral Contraceptives in the United States." American Journal of Obstetrics and Gynecology, Vol. 180, pp. 241-249, Jan. 1999

"European evaluation concludes third generation pills are associated with a small increase in risk of venous thromboembolism" British Medical Journal. 323:828. October 13, 2001. http://bmj.bmjjournals.com. Accessed August 2005.

"FDA Approves Seasonale Oral Contraceptive" FDA Talk Paper/Press release. Sept. 5, 2003. http://www.fda.gov. Accessed August 2005.

Marchbanks, P.A, et al. "Oral Contraceptives and the Risk of Breast Cancer" NEJM 2002. Vol. 346:2025-2032, No. 26.

"Oral Contraceptives and Cancer Risk." National Cancer Institute. http://cis.nci.nih.gov. Last updated: Nov. 3, 2003. Accessed August 2005.

"Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of a BRCA1 or BRCA2 Mutation." New England Journal of Medicine 345(4): 235-240. July 26, 2001. http://content.nejm.org Accessed: August 2005.

"Oral Contraceptives—An Update." Population Reports/The Johns Hopkins School of Public Health, Center for Communication Programs. http://www.infoforhealth.org. Date created: Spring 2000. Accessed August 2005.

"Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives." The Lancet 2001;358:1427-1429.

Schless, J.J. and Farley, T.M.M. Risk of cardiovascular disease in relation to oral contraception use with and without blood-pressure screening. Draft, Feb. 2000. Presented to meeting on Improving Access and Quality of Care in Family Planning: Medical Eligibility Criteria for Contraceptive Use, World Health Organization, Geneva, Mar. 8€10, 2000. 27 p.

"Stroke and Use of Low-Dose Oral Contraceptives in Young Women: A Pooled Analysis of Two US Studies." Stroke/American Heart Association. http://stroke.ahajournals.org. Date created: August 28, 1990. Accessed August 2005.

"Women in the Know." Ortho-McNeil Pharmaceutical, Inc. 2001. http://www.womenintheknow.com

"FDA Takes Action on Plan B: Statement by FDA Commissioner Lester M. Crawford." FDA press release. http://www.fda.gov. Date created: August 26, 2005. Date Accessed August 2005.

"What Is Thrombosis?" INvestigators Against ThromboEmbolism. http://www.inate.org. Date Accessed September 2005

"Pelvic Inflammatory Disease - CDC Fact Sheet." Centers for Disease Control. http://www.cdc.gov. Date reviewed May 2004. Accessed September 2005.

Petitti, DB. "Clinical practice. Combination Estrogen-progestin Oral Contraceptives." N Engl J Med 2003 Oct 9;349(15):1443-50.

"Choosing the Right Birth Control for Your Patients." The American College of Osteopathic Family Physicians. 2004. Available at: http://www.acofp.org. Accessed October 2005.

"Emergency Contraception: History." Contraception Online. July 2004. Available online at http://www.contraceptiononline.org. Accessed October 2005.

Smith, JS et al. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 2003 Apr 5;361(9364):1159-67).

Dickinson, BD et al. Drug interactions between oral contraceptives and antibiotics. Obstet Gynecol 2001 Nov;98(5 Pt 1):853-60)

"FDA approves new indication for YAZ to treat emotional and physical symptoms of premenstrual dysphoric disorder." Berlex. October 2006.